Annual Cash & Cash Equivalents
$2.91 B
+$191.90 M+7.05%
December 31, 2023
Summary
- As of February 7, 2025, CME annual cash & cash equivalents is $2.91 billion, with the most recent change of +$191.90 million (+7.05%) on December 31, 2023.
- During the last 3 years, CME annual cash & cash equivalents has risen by +$1.28 billion (+78.30%).
- CME annual cash & cash equivalents is now at all-time high.
Performance
CME Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$2.32 B
+$532.20 M+29.73%
September 30, 2024
Summary
- As of February 7, 2025, CME quarterly cash and cash equivalents is $2.32 billion, with the most recent change of +$532.20 million (+29.73%) on September 30, 2024.
- Over the past year, CME quarterly cash and cash equivalents has increased by +$21.90 million (+0.95%).
- CME quarterly cash and cash equivalents is now -20.26% below its all-time high of $2.91 billion, reached on December 31, 2023.
Performance
CME Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
CME Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +7.0% | +0.9% |
| 3 y3 years | +78.3% | +9.0% |
| 5 y5 years | +111.9% | +9.0% |
CME Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +7.0% | -20.3% | +61.6% |
| 5 y | 5-year | at high | +87.7% | -20.3% | +172.6% |
| alltime | all time | at high | +9399.3% | -20.3% | +4727.1% |
CME Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $2.32 B(+29.7%) |
| Jun 2024 | - | $1.79 B(+24.6%) |
| Mar 2024 | - | $1.44 B(-50.7%) |
| Dec 2023 | $2.91 B(+7.1%) | $2.91 B(+26.6%) |
| Sep 2023 | - | $2.30 B(+22.3%) |
| Jun 2023 | - | $1.88 B(+20.1%) |
| Mar 2023 | - | $1.57 B(-42.5%) |
| Dec 2022 | $2.72 B(-4.0%) | $2.72 B(+27.7%) |
| Sep 2022 | - | $2.13 B(+13.3%) |
| Jun 2022 | - | $1.88 B(-8.1%) |
| Mar 2022 | - | $2.05 B(-27.8%) |
| Dec 2021 | $2.83 B(+73.6%) | $2.83 B(+94.3%) |
| Sep 2021 | - | $1.46 B(+35.0%) |
| Jun 2021 | - | $1.08 B(+15.4%) |
| Mar 2021 | - | $936.40 M(-42.7%) |
| Dec 2020 | $1.63 B(+5.3%) | $1.63 B(+22.6%) |
| Sep 2020 | - | $1.33 B(-5.2%) |
| Jun 2020 | - | $1.41 B(+65.0%) |
| Mar 2020 | - | $851.70 M(-45.1%) |
| Dec 2019 | $1.55 B(+12.9%) | $1.55 B(+28.2%) |
| Sep 2019 | - | $1.21 B(+29.0%) |
| Jun 2019 | - | $937.70 M(-6.0%) |
| Mar 2019 | - | $997.40 M(-27.4%) |
| Dec 2018 | $1.37 B(-27.8%) | $1.37 B(-2.3%) |
| Sep 2018 | - | $1.41 B(+28.0%) |
| Jun 2018 | - | $1.10 B(+40.1%) |
| Mar 2018 | - | $784.60 M(-58.8%) |
| Dec 2017 | $1.90 B(+1.9%) | $1.90 B(+16.7%) |
| Sep 2017 | - | $1.63 B(+19.7%) |
| Jun 2017 | - | $1.36 B(+5.8%) |
| Mar 2017 | - | $1.29 B(-31.1%) |
| Dec 2016 | $1.87 B(+10.4%) | $1.87 B(+31.5%) |
| Sep 2016 | - | $1.42 B(+22.3%) |
| Jun 2016 | - | $1.16 B(+1.3%) |
| Mar 2016 | - | $1.15 B(-32.3%) |
| Dec 2015 | $1.69 B(+23.9%) | $1.69 B(+18.0%) |
| Sep 2015 | - | $1.43 B(+24.6%) |
| Jun 2015 | - | $1.15 B(-32.1%) |
| Mar 2015 | - | $1.69 B(+24.1%) |
| Dec 2014 | $1.37 B(-44.7%) | $1.37 B(+25.6%) |
| Sep 2014 | - | $1.09 B(+4.9%) |
| Jun 2014 | - | $1.04 B(-1.6%) |
| Mar 2014 | - | $1.05 B(-57.3%) |
| Dec 2013 | $2.47 B | $2.47 B(+19.6%) |
| Sep 2013 | - | $2.06 B(+4.9%) |
| Jun 2013 | - | $1.97 B(+6.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2013 | - | $1.84 B(+14.9%) |
| Dec 2012 | $1.60 B(+54.0%) | $1.60 B(-20.4%) |
| Sep 2012 | - | $2.02 B(+56.0%) |
| Jun 2012 | - | $1.29 B(+21.8%) |
| Mar 2012 | - | $1.06 B(+1.9%) |
| Dec 2011 | $1.04 B(+21.9%) | $1.04 B(+25.7%) |
| Sep 2011 | - | $829.30 M(+19.6%) |
| Jun 2011 | - | $693.60 M(+4.3%) |
| Mar 2011 | - | $664.70 M(-22.3%) |
| Dec 2010 | $855.20 M(+228.2%) | $855.20 M(+50.5%) |
| Sep 2010 | - | $568.20 M(+56.3%) |
| Jun 2010 | - | $363.60 M(-18.1%) |
| Mar 2010 | - | $444.20 M(+70.5%) |
| Dec 2009 | $260.60 M(-12.5%) | $260.60 M(+27.7%) |
| Sep 2009 | - | $204.10 M(-54.5%) |
| Jun 2009 | - | $448.70 M(+32.3%) |
| Mar 2009 | - | $339.20 M(+13.9%) |
| Dec 2008 | $297.90 M(-64.8%) | $297.90 M(-48.9%) |
| Sep 2008 | - | $582.42 M(-45.4%) |
| Jun 2008 | - | $1.07 B(+0.1%) |
| Mar 2008 | - | $1.07 B(+26.1%) |
| Dec 2007 | $845.31 M(-12.8%) | $845.31 M(+24.9%) |
| Sep 2007 | - | $677.03 M(-42.4%) |
| Jun 2007 | - | $1.17 B(+3.1%) |
| Mar 2007 | - | $1.14 B(+17.6%) |
| Dec 2006 | $969.50 M(+58.7%) | $969.50 M(+11.6%) |
| Sep 2006 | - | $868.62 M(+11.1%) |
| Jun 2006 | - | $782.14 M(+9.3%) |
| Mar 2006 | - | $715.68 M(+17.2%) |
| Dec 2005 | $610.89 M(+70.8%) | $610.89 M(+4.3%) |
| Sep 2005 | - | $585.66 M(+17.4%) |
| Jun 2005 | - | $498.97 M(+15.9%) |
| Mar 2005 | - | $430.62 M(+20.4%) |
| Dec 2004 | $357.56 M(+93.1%) | $357.56 M(+26.4%) |
| Sep 2004 | - | $282.78 M(+27.2%) |
| Jun 2004 | - | $222.34 M(+18.3%) |
| Mar 2004 | - | $187.99 M(+1.5%) |
| Dec 2003 | $185.12 M(-45.4%) | $185.12 M(-52.7%) |
| Sep 2003 | - | $391.53 M(-0.3%) |
| Jun 2003 | - | $392.83 M(+10.1%) |
| Mar 2003 | - | $356.95 M(+5.2%) |
| Dec 2002 | $339.26 M(+391.0%) | $339.26 M(+72.1%) |
| Sep 2002 | - | $197.16 M(+309.9%) |
| Jun 2002 | - | $48.11 M(-27.0%) |
| Mar 2002 | - | $65.90 M(-4.6%) |
| Dec 2001 | $69.10 M(+125.4%) | $69.10 M |
| Dec 2000 | $30.66 M | - |
FAQ
- What is CME annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for CME?
- What is CME annual cash & cash equivalents year-on-year change?
- What is CME quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for CME?
- What is CME quarterly cash and cash equivalents year-on-year change?
What is CME annual cash & cash equivalents?
The current annual cash & cash equivalents of CME is $2.91 B
What is the all time high annual cash & cash equivalents for CME?
CME all-time high annual cash & cash equivalents is $2.91 B
What is CME annual cash & cash equivalents year-on-year change?
Over the past year, CME annual cash & cash equivalents has changed by +$191.90 M (+7.05%)
What is CME quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of CME is $2.32 B
What is the all time high quarterly cash and cash equivalents for CME?
CME all-time high quarterly cash and cash equivalents is $2.91 B
What is CME quarterly cash and cash equivalents year-on-year change?
Over the past year, CME quarterly cash and cash equivalents has changed by +$21.90 M (+0.95%)